MDoutlook is a leading disease intelligence company.
We build the success of your organization through better decision-making.


Specializing in oncology, rare and ultra-rare diseases, we answer your business questions using custom market research instruments, our proprietary disease panels, our client side experience and our depth of clinical understanding.


Driven by staff medical experts, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.


Our solutions
MDoutlook provides custom and syndicated market research, ThoughtLeader identification and network mapping, and guaranteed physician engagement.


Click on the above icons to explore how our clients derive value.

What's New at MDoutlook

Rare cancers prominent ahead of the conference season

02 May 2019

Rare cancers feature more prominently at this year’s conference season, and ASCO has named "Progress in Treating Rare Cancers" as their advance of the year.…


Join our fast growing team

29 Apr 2019

MDoutlook is continuing its fast growth path. To support our growth, and overall client services and experience, we are keen to add a Manager, Strategic…


Biomarkers are valued but 1 in 3 oncologists want improvement

16 Apr 2019

Biomarkers are embraced by oncologists as an important tool in their arsenal to treat cancer. They enable a more personalized approach to treatment by identifying…


What's Trending in Oncology (updated hourly)